Verition Fund Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
+69,324
New +$1.62M 0.01% 1124
2025
Q1
Sell
-16,671
Closed -$433K 3344
2024
Q4
$433K Sell
16,671
-2,737
-14% -$68.1K ﹤0.01% 2562
2024
Q3
$486K Sell
19,408
-2,231
-10% -$52.7K ﹤0.01% 2347
2024
Q2
$464K Buy
+21,639
New +$420K ﹤0.01% 2091
2021
Q4
Sell
-11,303
Closed -$478K 2546
2021
Q3
$478K Buy
+11,303
New +$544K ﹤0.01% 1246
2015
Q2
Sell
-113,972
Closed -$183K 619
2015
Q1
$183K Sell
113,972
-26,153
-19% -$48.9K 0.02% 323
2014
Q4
$230K Hold
140,125
0.05% 204
2014
Q3
$294K Sell
140,125
-10
-0% -$24 0.04% 399
2014
Q2
$320K Buy
+140,135
New +$378K 0.03% 397

Other funds holding BLFS

Verition Fund Management's BLFS Position: Q2 2026 in Review

Verition Fund Management opened a new position in BioLife Solutions (BLFS) in Q2 2026: 69,324 shares worth $1.96M. The stake represents 0.01% of the portfolio and ranks #1124 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in BLFS as recently as Q4 2024.

Verition Fund Management first reported a position in BLFS in Q2 2014 and has held it in 9 quarters since. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Verition Fund Management held 69,324 shares of BioLife Solutions worth $1.96M as of Q2 2026.
  • BioLife Solutions was a new Verition Fund Management position in Q2 2026.
  • BioLife Solutions made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1124 holding.
  • Verition Fund Management first reported a position in BioLife Solutions in Q2 2014 and has held it in 9 quarters since.
  • 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.